Mer plays a role in multiple myeloma and acute lymphoblastic leukemia [21–23], it was promoted as a novel therapeutic target in GBM [24] and co-expression with Axl correlated with worse survival in gastric cancer [25]. The gene discussed is AXL; the disease is glioblastoma.